BR9814497A - Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular - Google Patents

Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular

Info

Publication number
BR9814497A
BR9814497A BR9814497-9A BR9814497A BR9814497A BR 9814497 A BR9814497 A BR 9814497A BR 9814497 A BR9814497 A BR 9814497A BR 9814497 A BR9814497 A BR 9814497A
Authority
BR
Brazil
Prior art keywords
prevent
glaucoma
visual field
loss associated
ocular hypertension
Prior art date
Application number
BR9814497-9A
Other languages
English (en)
Inventor
Angela C Kothe
Lewis H Silver
Thomas R Dean
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR9814497A publication Critical patent/BR9814497A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"PROCESSO PARA PREVENIR OU RETARDAR PERDA DE CAMPO VISUAL ASSOCIADA COM GLAUCOMA OU HIPERTENSãO OCULAR, E, USO DE BRINZOLAMIDA NA FABRICAçãO DE UM MEDICAMENTO TóPICO" Processos para prevenir ou retardar perda visual são apresentados.
BR9814497-9A 1997-12-23 1998-11-05 Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular BR9814497A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6876797P 1997-12-23 1997-12-23
PCT/US1998/023610 WO1999032123A1 (en) 1997-12-23 1998-11-05 The use of brinzolamide to prevent visual field loss

Publications (1)

Publication Number Publication Date
BR9814497A true BR9814497A (pt) 2000-10-10

Family

ID=22084577

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814497-9A BR9814497A (pt) 1997-12-23 1998-11-05 Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular

Country Status (12)

Country Link
US (1) US6242441B1 (pt)
EP (1) EP1047429A1 (pt)
JP (1) JP2001526231A (pt)
KR (1) KR20010015810A (pt)
CN (1) CN1178661C (pt)
AR (1) AR007230A1 (pt)
AU (1) AU750536B2 (pt)
BR (1) BR9814497A (pt)
CA (1) CA2310230C (pt)
TW (1) TWI241186B (pt)
WO (1) WO1999032123A1 (pt)
ZA (1) ZA9810837B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201210584A (en) 2010-08-18 2012-03-16 Alcon Res Ltd Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
US6242441B1 (en) 2001-06-05
EP1047429A1 (en) 2000-11-02
AU1310599A (en) 1999-07-12
JP2001526231A (ja) 2001-12-18
CN1178661C (zh) 2004-12-08
CA2310230A1 (en) 1999-07-01
CA2310230C (en) 2008-05-06
TWI241186B (en) 2005-10-11
WO1999032123A1 (en) 1999-07-01
AR007230A1 (es) 1999-10-27
AU750536B2 (en) 2002-07-18
ZA9810837B (en) 1999-07-20
KR20010015810A (ko) 2001-02-26
CN1280496A (zh) 2001-01-17

Similar Documents

Publication Publication Date Title
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
BR9905852A (pt) Poliuretanos termoplásticos alifáticos, processo para sua preparação e seu emprego
BR9910251A (pt) Estimulação hematopoiética
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
DK0712426T3 (da) Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf
BR9604878A (pt) Preparado oftálmico em gel gotejável estéril e processo para sua preparação
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
BR9609297A (pt) Processo para aumentar of fluxor sanguineo na retina
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
CA2316447A1 (en) Rantes mutants and therapeutic applications thereof
FI973184A0 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
BR9814188A (pt) "agonistas de 5-ht1f"
BR9814497A (pt) Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
BR9606955A (pt) Heterocicloalquenos substituísos
PT83253B (pt) Processo para a preparacao de p-acilaminobenzamidas
BR9600773A (pt) Benzenossulfonilurélas ou - tiourélas substituídas processo para sua preparação uso e medicamento
IT1281498B1 (it) Pirazolo - derivati ad attivita' antitumorale, processo per la loro preparazione e composizioni farmaceutiche che li contengono , e
DE60003074D1 (de) Fusidinsäure-derivate
IT9048335A0 (it) Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido o quello centrale.
DK0865436T3 (da) Dithiazoldioxider samt deres anvendelse som mikrobicider
BR9607850A (pt) Processo para a preparação de um composto e composto

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]